Professor Guy Rouleau and his team from the Faculty of Medicine, University of Montreal, have discovered in patients with sensory neuropathy, gene mutations K1F1A. “This result opens the door to a better understanding of this disease,” says Guy Rouleau. “We also take away valuable information about the molecular mechanisms involved in pain perception.”
It is therefore an important discovery. Eventually, a drug could be developed by modulating the interactions between different proteins associated with pain and K1F1A gene.